Immune cells in cerebrospinal fluid could be novel biomarkers to immune-based therapi

[News]

Results from a study led by Joan Seoane, Director of Preclinical and Translational Research co-program at VHIO and ICREA Professor, show that immune cells accessing cerebrospinal fluid faithfully recapitulate the characteristics of cells identified in brain metastasis, and could therefore constitute novel biomarkers of response to immune-based therapies.

More... (https://www.news-medical.net/news/20210308/Immune-cells-in-cerebrospinal-fluid-could-be-novel-biomarkers-to-immune-based-therapies.aspx)